Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses

Transplantation

Volumn 65, Issue 9, 1998, Pages 1145-1152

  He, Xiao Yan ^a   Chen, Juchuan ^a   Verma, Nirupama ^a   Plain, Karren ^a   Tran, Giang ^a   Hall, Bruce M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MRC OX 35; MONOCLONAL ANTIBODY MRC OX 81; OKT 4; RECOMBINANT INTERLEUKIN 4; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CHO CELLS; CRICETINAE; CYTOKINES; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTERLEUKIN-4; ISOANTIBODIES; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; RATS; RATS, INBRED STRAINS; RECOMBINANT PROTEINS; RNA, MESSENGER; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0000443849     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199805150-00001     Document Type: Article

References (50)

1. Paul WE. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 1991; 77(9): 1859.
2. Vicari A, Papiernik M. Multiple effects caused by anti-IL-4 mAb inoculation in the thymus and spleen of adult mice. Eur Cytokine Network 1993; 4(2): 111.
3. Macedo-Soares F, Latinne D, Denis O, Bazin H. In vivo interleukin-4 regulation of antibody responses in euthymic and athymic mice to a T-independent antigen (hydroxyethyl starch). Int Arch Allergy Immunol 1996; 110(2): 174.
4. Ohmori H, Hase N, Hikida M, Takai T, Endo N. Enhancement of antigen-induced interleukin 4 and IgE production by specific IgG1 in murine lymphocytes. Cell Immunol 1992; 145(2): 299.
5. + T cells from T cell receptor transgenic mice. J Exp Med 1992; 176(4): 1091.
6. Abehsira-Amar O, Gibert M, Joliy M, Theze J, Jankovic DL. IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells. J Immunol 1992; 148(12): 3820.
7. Erard F, Wild MT, Garcia-Sanz JA, Le GG. Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells. Science 1993; 260(5115): 1802.
8. Swain SL. CD4 T cell development and cytokine polarization: an overview. J Leukoc Biol 1995; 57(5): 795.
9. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145.
10. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174(2): 493.
11. O'Connell PJ, Pacheco-Silva A, Nickerson PW, et al. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol 1993; 150(3): 1093.
12. Egawa H, Martinez OM, Quinn MB, et al. Acute liver allograft rejection in the rat: an analysis of the immune response. Transplantation 1995; 59(1): 97.
13. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems: the differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53(6): 1281.
14. Mottram PL, Han WR, Purcell LJ, McKenzie IFC, Hancock WW. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-γ in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 1995; 59(4): 559.
15. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995; 13: 151.
16. Hall BM, deSaxe I, Dorsch SE. The cellular basis of allograft rejection in vivo. III. Restoration of first-set rejection of heart grafts by T helper cells in irradiated rats. Transplantation 1983; 36(6): 700.
17. Hall BM. Cells mediating allograft rejection [published erratum appears in Transplantation 1991; 52(5): 936]. Transplantation 1991; 51(6): 1141.
18. Merton S, Chen JC, Ha H, et al. The cellular basis of allograft rejection. VIII. Mechanisms underlying delayed graft rejection in PVGC6 deficient rats. Transplantation 1998; in press.
19. Hall BM, Jelbart ME, Gurley KE, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine: mediation of specific suppression by T helper/inducer cells. J Exp Med 1985; 162(5): 1683.
20. Levy AE, Alexander JW. Administration of intragraft interleukin-4 prolongs cardiac allograft survival in rats treated with donor-specific transfusion/cyclosporin. Transplantation 1995; 60(5): 405.
21. Chen N, Field EH. Enhanced type 2 and diminished type 1 cytokines in neonatal tolerance. Transplantation 1995; 59(7): 933.
22. Donckier V, Wissing M, Bruyns C, et al. Critical role of interleukin 4 in the induction of neonatal transplantation tolerance. Transplantation 1995; 59(11): 1571.
23. + T cell subsets in low- and high-responder rat strains. J Immunol 1989; 143(9): 2828.
24. Nicolls MR, Aversa GG, Pearce NW, et al. Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody. Transplantation 1993; 55(3): 459.
25. McKnight AJ, Barclay AN, Mason DW. Molecular cloning of rat interleukin 4 cDNA and analysis of the cytokine repertoire of subsets of CD4+ T cells. Eur J Immunol 1991; 21(5): 1187.
26. + T cells in vitro. J Immunol 1996; 156: 2406.
27. Wotherspoon JS, Dorsch SE. The mechanism of prolonged graft survival following removal of the regional lymph node. Transplantation 1986; 42: 532.
28. DeFoma FJ, MacDonald AB. Analysis of antigens by immunodiffusion and immunoelectrophoresis. In: DeFoma FJ, MacDonald AB, eds. Experimental immunology: a guidebook. New York: Macmillan, 1987: 49.
29. Plain KM, Fava L, Spinelli A, et al. Induction of tolerance with nondepleting anti-CD4 monoclonal antibody is associated with down regulation of Th2 cytokines. Transplantation 1997; 64: 1559.
30. Leenaerts PL, De RD, Vandeputte M, Waer M. Measurement of alloantibody by flow cytometry. J Immunol Methods 1990; 130(1): 73.
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162(1): 156.
32. Penny MJ, Boyd RA, Hall BM. Role of T cells in the mediation of Heymann nephritis. II. Identification of Th1 and cytotoxic cells in glomeruli. Kidney Int 1997; 51: 1059.
33. Dallman MJ, Porter ACG. Semi-quantitative PCR for the analysis of gene expression. In: McPherson MJ, Quirke P, Taylor GR, eds. PCR: a practical approach. Oxford: IRL Press, 1991: 215.
34. Takeuchi T, Ueki T, Sunaga S, et al. Murine interleukin 4 transgenic heart allograft survival prolonged with down-regulation of TH1 cytokine mRNA in grafts. Transplantation 1997; 64(1): 152.
35. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF, Rajotte RV. Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Transplantation 1995; 60(4): 368.
36. Racke MK, Bonomo A, Scott DE, et al. Cytokine-induced immune deviation as therapy for inflammatory autoimmune disease. J Exp Med 1994; 180: 1961.
37. Powrie F, Menon S, Coffman RL. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo [published erratum appears in Eur J Immunol 1994; 24(3): 785]. Eur J Immunol 1993; 23(9): 2223.
38. Nickerson P, Steiger J, Zheng XX, et al. Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance? Transplantation 1997; 63(4): 489.
39. Vossen ACTM, Tibbe GJM, Benner R, Savelkoul HFJ. T-lymphocyte and cytokine-directed stratergies for inhibiting skin allograft rejection in mice. Transplant Proc 1995; 27(1): 380.
40. Anderson GP, Coyle AJ. TH2 and "TH2-like" cells in allergy and asthma: pharmacological perspectives [see comments]. Trends Pharmacol Sci 1994; 15(9): 324.
41. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181(5): 1869.
42. Chen ZK, Cobbold SP, Waldmann H, Metcalfe S. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 1996; 62(9): 1200.
43. Lowry RP, Takeuchi T, Cremisi H, Konieczny B. Th2-like effectors may function as antigen-specific suppressor cells in states of transplantation tolerance. Transplant Proc 1993; 25 (1 Pt 1): 324.
44. Nickerson P, Steurer W, Steiger J, Zheng X, Steele AW, Strom TB. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 1996; 6(5): 757.
45. Field EH, Gao Q, Chen N, Rouse TM. Balancing the immune system for tolerance. Transplantation 1997; 64(1): 1.
46. Abramowicz D, Vandervorst P, Bruyns C, Doutrelepont JM, Vandenabeele P, Goldman M. Persistence of anti-donor allohelper T cells after neonatal induction of allotolerance in mice. Eur J Immunol 1990; 20: 1647.
47. Donckier V, Wissing M, Abramowicz D, et al. Early neutralization of IL-4 but not of IL-10 abrogates neonatal induction of transplantation tolerance in mice. Transplant Proc 1995; 27(1): 186.
48. Gao Q, Chen N, Rouse TM, Field EH. The role of IL-4 in the induction phase of allogeneic neonatal tolerance. Transplantation 1996; 59: 1571.
49. Wasowska B, Wieder KJ, Hancock WW, et al. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin. J Immunol 1996; 156(1): 395.
50. Hall BM. Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell. J Exp Med 1985; 161(1): 123.